# Effect of RYGB on Alpha- and Beta Cell Function and Sensitivity to Incretins in Patients With Type 2 Diabetes

> **NCT04782999** · NA · COMPLETED · sponsor: **Hvidovre University Hospital** · enrollment: 9 (actual)

## Conditions studied

- Type2 Diabetes
- Obesity, Morbid

## Interventions

- **DIAGNOSTIC_TEST:** Oral Glucose Tolerance Test
- **DIAGNOSTIC_TEST:** Hyperglycemic clamp with infusion of saline, GLP-1 or GIP

## Key facts

- **NCT ID:** NCT04782999
- **Lead sponsor:** Hvidovre University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2022-01
- **Final completion:** 2022-03
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2022-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04782999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04782999, "Effect of RYGB on Alpha- and Beta Cell Function and Sensitivity to Incretins in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04782999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*